Trends in life expectancy in EU and other OECD countries

V. Raleigh
{"title":"Trends in life expectancy in EU and other OECD countries","authors":"V. Raleigh","doi":"10.1787/223159AB-EN","DOIUrl":null,"url":null,"abstract":"This paper reports on trends in life expectancy in the 28 EU countries and some other high-income OECD countries, and examines potential explanations for the slowdown in improvements in recent years. The slowdown in improvements in life expectancy since 2011 has been greatest in the USA, where life expectancy has fallen in recent years, and the UK, but France, Germany, Sweden and Netherlands have also seen a sharp slowdown. Overall, the pace of mortality improvement has slowed in several EU countries and Australia and Canada since 2011. Diseases of older ages are major contributors to the slowdown. Improvements in cardiovascular (CVD) disease mortality have slowed in many countries, respiratory diseases, including influenza and pneumonia, have claimed excess lives in some winters, and deaths from dementia and Alzheimer's disease are rising. In some countries, notably the USA and the UK, mortality improvements have also slowed or even reversed among working age adults because of the rising numbers dying from drug-related accidental poisoning. The report also considers wider contributing factors. Although some risk factors, such as smoking, excessive alcohol consumption, high blood pressure and cholesterol levels, continue to decline in most EU countries, the prevalence of obesity and diabetes continues to rise. Adverse trends in inequalities could also have an impact if some population groups experience lower gains in longevity than others, thereby reducing the overall gain. Looking ahead, it is unclear whether the current slowdown in mortality improvements in some EU countries and the USA is a long-term trend or not, whether the slowdown in major killers such as CVD will persist, and whether or not the excess winter mortality seen in some years becomes a regular feature given population ageing and increasing numbers of frail, older people. The timely monitoring and investigation of mortality trends, including through international collaboration where possible, can facilitate early implementation of remedial strategies.","PeriodicalId":302579,"journal":{"name":"OECD Health Working Papers","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"48","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"OECD Health Working Papers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1787/223159AB-EN","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 48

Abstract

This paper reports on trends in life expectancy in the 28 EU countries and some other high-income OECD countries, and examines potential explanations for the slowdown in improvements in recent years. The slowdown in improvements in life expectancy since 2011 has been greatest in the USA, where life expectancy has fallen in recent years, and the UK, but France, Germany, Sweden and Netherlands have also seen a sharp slowdown. Overall, the pace of mortality improvement has slowed in several EU countries and Australia and Canada since 2011. Diseases of older ages are major contributors to the slowdown. Improvements in cardiovascular (CVD) disease mortality have slowed in many countries, respiratory diseases, including influenza and pneumonia, have claimed excess lives in some winters, and deaths from dementia and Alzheimer's disease are rising. In some countries, notably the USA and the UK, mortality improvements have also slowed or even reversed among working age adults because of the rising numbers dying from drug-related accidental poisoning. The report also considers wider contributing factors. Although some risk factors, such as smoking, excessive alcohol consumption, high blood pressure and cholesterol levels, continue to decline in most EU countries, the prevalence of obesity and diabetes continues to rise. Adverse trends in inequalities could also have an impact if some population groups experience lower gains in longevity than others, thereby reducing the overall gain. Looking ahead, it is unclear whether the current slowdown in mortality improvements in some EU countries and the USA is a long-term trend or not, whether the slowdown in major killers such as CVD will persist, and whether or not the excess winter mortality seen in some years becomes a regular feature given population ageing and increasing numbers of frail, older people. The timely monitoring and investigation of mortality trends, including through international collaboration where possible, can facilitate early implementation of remedial strategies.
欧盟和其他经合组织国家的预期寿命趋势
本文报告了28个欧盟国家和其他一些经合组织高收入国家的预期寿命趋势,并探讨了近年来改善速度放缓的潜在解释。自2011年以来,预期寿命改善的放缓在美国和英国最为明显,近年来预期寿命有所下降,但法国、德国、瑞典和荷兰也出现了大幅放缓。总体而言,自2011年以来,几个欧盟国家以及澳大利亚和加拿大的死亡率下降速度有所放缓。老年疾病是人口增长放缓的主要原因。在许多国家,心血管疾病死亡率的下降速度有所放缓,包括流感和肺炎在内的呼吸系统疾病在某些冬季夺走了更多的生命,痴呆症和阿尔茨海默病造成的死亡人数正在上升。在一些国家,特别是美国和英国,由于死于与毒品有关的意外中毒的人数不断上升,工作年龄成年人的死亡率下降速度也有所放缓,甚至出现逆转。该报告还考虑了更广泛的影响因素。尽管在大多数欧盟国家,吸烟、过度饮酒、高血压和胆固醇水平等一些风险因素继续下降,但肥胖和糖尿病的患病率继续上升。如果某些人口群体的寿命增长低于其他人口群体,则不平等的不利趋势也可能产生影响,从而降低总体增长。展望未来,目前尚不清楚在一些欧盟国家和美国,目前死亡率改善的放缓是否是一个长期趋势,心血管疾病等主要杀手的放缓是否会持续下去,以及考虑到人口老龄化和体弱多病的老年人数量增加,某些年份冬季死亡率过高是否会成为一种常规特征。及时监测和调查死亡率趋势,包括在可能的情况下通过国际合作,可促进及早执行补救战略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信